Since the introduction of the Marquette 12SL Analysis Program in 1980, GE Healthcare has consistently expanded its electrocardiograph-based suite of ECG analysis programs and capabilities. Today, we continue to lead developments in computerized ECG analysis – setting even higher levels of clinical accuracy, validity, and performance. Our commitment to improving the science of ECG interpretation has led to the use of our analysis programs across GE diagnostic ECG and monitoring systems, as well as implementation into other industry-leading products. This implementation makes our programs a preferred choice in a variety of care settings and industries, including emergency medicine, inpatient, outpatient, and clinical research organizations (CRO’s).